Oral

Novo Nordisk Shares Surge Nearly 10% on Oral Wegovy Approval

Business Pen
[stock_market_widget type=”card” template=”basic” color=”#5679FF” assets=”NVO” realtime=”true” api=”yahoo-finance”] Novo Nordisk A/S (NYSE: NVO, CPH: NOVO-B) opened trading over 9% higher after U.S. regulators cleared an oral...

Subscribe to Newsletter